Virtus Lifesci Biotech Clinical Trials ETF (BBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBC | VHT | XBI | ||
| Company | Virtus Lifesci Biotech Clinical Trials ETF | Healthcare ETF Vanguard | S&P Biotech SPDR | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NYSE Arca | ||
| Open | 38.62 | 289.18 | 123.77 | ||
| High | 38.71 | 289.51 | 124.18 | ||
| Low | 38.26 | 286.75 | 122.69 | ||
| Latest | 38.49 | 287.20 | 123.41 | ||
| Change | +0.30 | -1.13 | +0.16 | ||
| % Change | +0.80% | -0.39% | +0.13% | ||
| Volume | 24,000 | 194,900 | 7,524,600 | ||
| 20-Day Average Volume | 27,520 | 294,510 | 11,800,200 | ||
| Previous Close | 38.19 | 288.33 | 123.25 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 34.57 | 285.95 | 117.09 | ||
| 20-Day Raw Stochastic | 97.88% | 65.17% | 95.69% | ||
| 20-Day Relative Strength | 70.50 | 60.76 | 68.31 | ||
| Weighted Alpha | +80.40 | +13.02 | +42.81 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 80% Buy | 88% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.76% since 11/28/25 | -2.49% since 11/28/25 | +0.20% since 11/28/25 | ||
| Low | 35.14 on 12/02/25 | 286.74 on 12/05/25 | 117.72 on 12/02/25 | ||
| High | 38.71 on 12/05/25 | 294.60 on 12/01/25 | 124.18 on 12/05/25 | ||
| 1-Month | |||||
| %Chg | +28.53% since 11/05/25 | +5.53% since 11/05/25 | +13.00% since 11/05/25 | ||
| Low | 28.73 on 11/07/25 | 269.78 on 11/07/25 | 106.30 on 11/07/25 | ||
| High | 38.71 on 12/05/25 | 296.51 on 11/26/25 | 124.18 on 12/05/25 | ||
| 3-Month | |||||
| %Chg | +57.89% since 09/05/25 | +11.75% since 09/05/25 | +29.27% since 09/05/25 | ||
| Low | 23.81 on 09/15/25 | 249.57 on 09/25/25 | 92.64 on 09/15/25 | ||
| High | 38.71 on 12/05/25 | 296.51 on 11/26/25 | 124.18 on 12/05/25 | ||
| 6-Month | |||||
| %Chg | +94.82% since 06/05/25 | +17.06% since 06/05/25 | +49.48% since 06/05/25 | ||
| Low | 18.77 on 06/23/25 | 237.23 on 08/07/25 | 80.90 on 06/23/25 | ||
| High | 38.71 on 12/05/25 | 296.51 on 11/26/25 | 124.18 on 12/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 25,021 | 16,933,312 | 7,490,987 | ||
| Shares Outstanding, K | 650 | 58,960 | 60,700 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 1.01 | 0.67 | 0.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Latest Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.239 on 12/20/24 | 1.077 on 09/24/25 | 0.027 on 09/22/25 | ||
| Next Ex-Dividends Date | 12/20/24 | 09/24/25 | 09/22/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.40 | 16.40 | ||